Invited commentary: Identifying women with hypertension during pregnancy - Is high specificity sufficient?

American Journal of Epidemiology

Volumn 166, Issue 2, 2007, Pages 125-127

  Callaghan, William M ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Hypertension; Pregnancy; Sensitivity and specificity; Women

Indexed keywords

ETIOLOGY; HYPERTENSION; INFANT MORTALITY; MORBIDITY; PREGNANCY; WOMENS HEALTH;

HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; NEWBORN MORBIDITY; NEWBORN MORTALITY; OUTCOMES RESEARCH; PATIENT CODING; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; SENSITIVITY AND SPECIFICITY; CLASSIFICATION; FEMALE; NOTE;

FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INTERNATIONAL CLASSIFICATION OF DISEASES; PREGNANCY; SENSITIVITY AND SPECIFICITY;

EID: 34547611653     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwm141     Document Type: Review

References (25)

1. Berg CJ, Chang J, Callaghan WM, et al. Pregnancy-related mortality in the United States 1991-1997. Obstet Gynecol 2003;101:289-96.
2. Wildman K, Bouvier-Colle MH. Maternal mortality as an indicator of obstetric care in Europe. BJOG 2004;111:164-9.
3. Working Group report on high blood pressure in pregnancy. Bethesda, MD: National Institutes of Health, 2000. (NIH publication no. 00-3029).
4. Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 2001;357:209-15.
5. American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002;99:159-67. (ACOG practice bulletin no. 33).
6. Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 2002;287:3183-6.
7. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:181-92.
8. Klemmensen AK, Olsen SF, Wengel CM, et al. Diagnostic criteria and reporting procedures for pre-eclampsia: a national survey among obstetrical departments in Denmark. Eur J Obstet Gynecol Reprod Biol 2005;123:41-5.
9. Geller SE, Ahmed S, Brown ML, et al. International classification of diseases. Ninth Revision. Revision coding for pre-eclampsia: how accurate is it? Am J Obstet Gynecol 2004;190:1629-34.
10. Buchbinder A, Sibai BM, Caritas S, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 2002;186:66-71.
11. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who develop hypertension. Obstet Gynecol 2000;95:24-8.
12. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785-99.
13. Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent preeclampsia. N Engl J Med 1997;337:69-76.
14. Skjaerven R, Vatten LJ, Wilcox AJ, et al. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ 2005;331:877-91.
15. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-83.
16. Levine RJ, Thadhani R, Qian C, et al. Urinary placental growth factor and risk of preeclampsia. JAMA 2005;293:77-85.
17. Wolf M, Shah A, Lam C, et al. Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies. Am J Obstet Gynecol 2005;193:16-22.
18. Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for pre-eclampsia. Obstet Gynecol 2004;104:1367-91.
19. Fayyad AM, Harrington KF. Prediction and prevention of preeclampsia and IUGR. Early Hum Dev 2005;81:865-76.
20. Poston L, Briley AI, Seed PT, et al. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomized placebo-controlled trial. Lancet 2006;367:1145-54.
21. Van Pampus MG, Aarnoudse JG. Long-term outcomes after preeclampsia. Clin Obstet Gynecol 2005;48:489-94.
22. Ramsay JE, Stewart F, Greer IA, et al. Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease. BJOG 2003;110:1029-31.
23. Ness RB, Hubel CA. Risk for coronary artery disease and morbid preeclampsia: a commentary. Ann Epidemiol 2005;15:726-33.
24. Roberts JM, Gammill H. Pre-eclampsia and cardiovascular disease in later life. Lancet 2005;366:961-2.
25. Klemmensen ÅK, Olsen SF, Østerdal ML, et al. Validity of preeclampsia-related diagnoses recorded in a national hospital registry and in a postpartum interview of the women. Am J Epidemiol 2007;166:117-24.